Cargando…
Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis
• Benign metastasizing leiomyomatosis (BML) is a rare condition. • Treatment options have traditionally included surgical resection or hormonal based therapy. • Traditional chemotherapy for BML is ineffective. • Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068955/ https://www.ncbi.nlm.nih.gov/pubmed/35531358 http://dx.doi.org/10.1016/j.gore.2021.100903 |